Advertisement

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

First International Summit on Interventional Pharmacoeconomics

Advertisement

Related Videos

Deborah Collyar: What's In It for Patients?

Victoria T. Brown, PharmD, BCOP, on Payer Intervention: The Example of Abiraterone

Welcome and Introduction to Vi3C

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

Advertisement

Advertisement

Oct

29

Today In Oncology

TIL Therapy Plus Pembrolizumab for Advanced Melanoma

Machine Learning Models Outperform Traditional Approaches to Multicancer Risk Prediction

Sacituzumab Tirumotecan Extends PFS OS in Advanced Recurrent Endometrial Cancer

Expert Histopathology and Molecular Testing Improve Diagnosis of Ambiguous Cutaneous Melanocytic Tumors

Radiation Added to Systemic Therapy Improves PFS But Not OS for Oligometastatic NSCLC

Advertisement

© 2026 HSP News Service, L.L.C.